Income Tax Expense (Benefit) in USD of Inhibrx, Inc. from Q3 2019 to Q1 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Inhibrx, Inc. quarterly/annual Income Tax Expense (Benefit) history and change rate from Q3 2019 to Q1 2024.
- Inhibrx, Inc. Income Tax Expense (Benefit) for the quarter ending 31 Mar 2024 was $0.000.
- Inhibrx, Inc. Income Tax Expense (Benefit) for the twelve months ending 31 Mar 2024 was $3K, unchanged year-over-year.
- Inhibrx, Inc. annual Income Tax Expense (Benefit) for 2023 was $3K, unchanged from 2022.
- Inhibrx, Inc. annual Income Tax Expense (Benefit) for 2022 was $3K, a 50% increase from 2021.
- Inhibrx, Inc. annual Income Tax Expense (Benefit) for 2021 was $2K, a 33.3% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)